Abeona Therapeutics (ABEO) Free Cash Flow (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Free Cash Flow of -$20.7 million for Q1 2026, down 12.94% year-over-year from -$23.8 million in Q1 2025, and down 75.52% quarter-over-quarter from -$11.8 million in Q4 2025.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Free Cash Flow (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Free Cash Flow history runs 16 years deep, the most recent figure standing at -$20.7 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 12.94% year-over-year to -$20.7 million; the TTM figure through Mar 2026 stood at -$79.4 million (down 34.7% YoY), while the FY2025 annual figure was -$77.0 million, down 37.93% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$20.7 million, down from -$11.8 million in the prior quarter.
- The five-year high for Free Cash Flow was -$5.8 million in Q3 2023, with the low at -$26.6 million in Q3 2025.
- The 5-year median for Free Cash Flow is -$13.4 million (2024), against an average of -$13.8 million.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow jumped 52.81% in 2022, then slumped 118.76% in 2024.
- Abeona Therapeutics' Free Cash Flow stood at -$14.3 million in 2022, then surged by 34.32% to -$9.4 million in 2023, then plunged by 55.11% to -$14.5 million in 2024, then climbed by 18.72% to -$11.8 million in 2025, then slumped by 75.52% to -$20.7 million in 2026.
- Business Quant data shows ABEO's Free Cash Flow at -$20.7 million in Q1 2026, -$11.8 million in Q4 2025, and -$26.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn | -17.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.98 Mn |
| Mar 31, 2026 | -20.74 Mn |
| Dec 31, 2025 | -19.11 Mn |
| Sep 30, 2025 | -23.71 Mn |
| Jun 30, 2025 | -21.69 Mn |
| Mar 31, 2025 | -19.80 Mn |
| Dec 31, 2024 | -17.17 Mn |
| Sep 30, 2024 | -12.64 Mn |
| Jun 30, 2024 | -13.40 Mn |
| Mar 31, 2024 | -15.26 Mn |
| Dec 31, 2023 | -9.27 Mn |
| Sep 30, 2023 | -5.79 Mn |
| Jun 30, 2023 | -10.32 Mn |
| Mar 31, 2023 | -11.96 Mn |
| Dec 31, 2022 | -14.27 Mn |
| Sep 30, 2022 | -6.79 Mn |
| Jun 30, 2022 | -9.01 Mn |
| Mar 31, 2022 | -13.54 Mn |
| Dec 31, 2021 | -33.51 Mn |
| Sep 30, 2021 | -10.74 Mn |